Evaluation of diagnostic efficacy of NRP‐1/CD304 in hematological diseases
Abstract Background Previous studies had explored the diagnostic or prognostic value of NRP‐1/CD304 in blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML), and B‐cell acute lymphoblastic leukemia (B‐ALL), whereas the expression and application value of NRP‐1/CD304 in o...
Main Authors: | Yi‐jun Liu, Xiao‐hui Li, Yi‐ling Song, Yi‐chen Zhou, Rong‐zeng Cai, Pei‐dong Chi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5838 |
Similar Items
-
Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia
by: Ibrahim Aldoss, et al.
Published: (2020-10-01) -
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients
by: Naveen Pemmaraju, et al.
Published: (2024-02-01) -
Natural Product Cordycepin (CD) Inhibition for NRP1/CD304 Expression and Possibly SARS-CoV-2 Susceptibility Prevention on Cancers
by: Ting Li, et al.
Published: (2023-12-01) -
Case Report: Mature Plasmacytoid Dendritic Cell Proliferation Associated With a Lymphoid Neoplasm
by: Fei Fei, et al.
Published: (2022-07-01) -
Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
by: Moizza Sahar, et al.
Published: (2019-05-01)